ArticleDigestive diseases and sciences2026
Does Quality of Life and Symptom Severity Correlate with Celiac Disease Serology in Adolescents?
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond Serology: Understanding Quality of Life in Adolescents with Celiac Disease.Digestive diseases and sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAdolescents with a new diagnosis of celiac disease (CeD) face challenges navigating social relationships while also managing symptoms and the gluten-free diet. The purpose of this study is to evaluate the relationship between quality of life (QoL), symptoms, and CeD serology in adolescents with CeD.
methodsCross-sectional survey study of adolescent patients (13-18 years old) within one year of biopsy-proven diagnosis of symptomatic CeD. Participants completed the PedsQL questionnaire, a health-related QoL assessment, and the Celiac Symptom Index (CSI), a measure of CeD-related symptoms. Tissue transglutaminase IgA (tTG-IgA) was used as a measure of disease activity. Means, mean difference, t test, and point biserial correlations were computed to assess the association of tTG-IgA with CSI and PedsQL scores.
resultsFifty-four adolescents and parents/guardians were surveyed. Thirty-seven had abnormal tTG-IgA and were compared to those with normal tTG-IgA. There were significant differences in overall PedsQL scores (84.75 vs 77.03, r = -0.28, p = 0.05), social subscores (95.42 vs 88.59, r = 0.24, p = 0.02), emotional subscores (80.83 vs 66.62, r =- 0.31, p = 0.03), and school functioning subscores (81.25 vs 68.89, r =- 0.36, p = 0.01). There was no significant relationship between tTG-IgA and the physical subscore or CSI score. Females report higher CSI scores and lower PedsQL scores. Older age at diagnosis was associated with lower PedsQL scores. DISCUSSION: Adolescents with abnormal tTG-IgA serology had lower QoL scores that were unrelated to measures of physical symptoms (CSI and physical subscore of PedsQL). This suggests more complex drivers of QoL that are not related to physical symptoms but are still associated with persistently elevated serology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.